Estrella Immunopharma Valuation
| ESLA Stock | 0.99 0.04 3.88% |
Today, the firm appears to be overvalued. Estrella Immunopharma shows a prevailing Real Value of USD0.93 per share. The current price of the firm is USD0.99. Our model computes the value of Estrella Immunopharma from reviewing the firm fundamentals such as Current Valuation of 15.43 M, shares owned by insiders of 72.08 %, and Shares Owned By Institutions of 0.80 % as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Estrella Immunopharma's valuation include:
Overvalued
Today
Please note that Estrella Immunopharma's price fluctuation is abnormally volatile at this time. Calculation of the real value of Estrella Immunopharma is based on 3 months time horizon. Increasing Estrella Immunopharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Estrella Immunopharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Estrella Stock. However, Estrella Immunopharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.99 | Real 0.93 | Hype 1.0 | Naive 0.83 |
The real value of Estrella Stock, also known as its intrinsic value, is the underlying worth of Estrella Immunopharma Company, which is reflected in its stock price. It is based on Estrella Immunopharma's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Estrella Immunopharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Estrella Immunopharma helps investors to forecast how Estrella stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Estrella Immunopharma more accurately as focusing exclusively on Estrella Immunopharma's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Estrella Immunopharma's intrinsic value based on its ongoing forecasts of Estrella Immunopharma's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Estrella Immunopharma's closest peers. If more than one evaluation category is relevant for Estrella Immunopharma we suggest using both methods to arrive at a better estimate.
Estrella Immunopharma Cash |
|
Estrella Valuation Trend
Comparing Estrella Immunopharma's enterprise value against its market capitalization is a good way to estimate the value of Estrella Immunopharma uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Estrella Immunopharma Total Value Analysis
Estrella Immunopharma is currently expected to have valuation of 15.43 M with market capitalization of 53.91 M, debt of 180.7 K, and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Estrella Immunopharma fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
15.43 M | 53.91 M | 180.7 K |
Estrella Immunopharma Asset Utilization
One of the ways to look at asset utilization of Estrella is to check how much profit was generated for every dollar of assets it reports. Estrella Immunopharma shows a negative utilization of assets of -0.35 percent, losing USD0.003545 for each dollar of assets held by the firm. Inadequate asset utilization denotes the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Estrella Immunopharma shows how discouraging it operates for each dollar spent on its assets.Estrella Immunopharma Ownership Allocation
Estrella Immunopharma holds a total of 36.18 Million outstanding shares. Estrella Immunopharma shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 72.08 percent of Estrella Immunopharma outstanding shares that are owned by insiders denotes they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Estrella Immunopharma Profitability Analysis
Net Loss for the year was (7.31 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Estrella Immunopharma's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Estrella Immunopharma and how it compares across the competition.
About Estrella Immunopharma Valuation
The stock valuation mechanism determines Estrella Immunopharma's current worth on a weekly basis. Our valuation model uses a comparative analysis of Estrella Immunopharma. We calculate exposure to Estrella Immunopharma's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Estrella Immunopharma's related companies.Estrella Immunopharma Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 35.2 M |
Estrella Immunopharma Current Valuation Indicators
Valuation refers to the process of determining the present value of Estrella Immunopharma and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Estrella we look at many different elements of the entity such as Estrella's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Estrella Immunopharma, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Estrella Immunopharma's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Estrella Immunopharma's worth.Complementary Tools for Estrella Stock analysis
When running Estrella Immunopharma's price analysis, check to measure Estrella Immunopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Estrella Immunopharma is operating at the current time. Most of Estrella Immunopharma's value examination focuses on studying past and present price action to predict the probability of Estrella Immunopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Estrella Immunopharma's price. Additionally, you may evaluate how the addition of Estrella Immunopharma to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |